Sarepta Therapeutics Overview

Industry
Biotechnology
Revenue
Headquarters
Employees
840
Founded In
Website
Organization Type
Public
CEO
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing.
The staff at Sarepta Therapeutics come from unusually diverse demographic backgrounds. The company is 56.4% female and 34.1% ethnic minorities. Despite its diversity in other areas, Sarepta Therapeutics employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 75.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Sarepta Therapeutics has great employee retention with staff members usually staying with the company for 5.0 years. The average employee at Sarepta Therapeutics makes $94,985 per year, which is competitive for its industry and location. Some of its highest paying competitors, Gilead Sciences, Vertex Pharmaceuticals, and Medivation, pay $99,828, $95,952, and $94,135, respectively.
Sarepta Therapeutics is a medium health care company with 840 employees and an annual revenue of $701.9M that is headquartered in Cambridge, MA.

The Organization’s Mission

To engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
-

Employee Reviews

Be the first to review!

Do you work at Sarepta Therapeutics?

Help us make this company more transparent

Job Openings
102 Positions
Average Salary
$94,985 yearly

The Team At Sarepta Therapeutics

Key People

Douglas S. Ingram

Marwan Fawaz

Sarepta Therapeutics Rankings

Sarepta Therapeutics is ranked #62 on the Best Health Care Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Sarepta Therapeutics Salaries

9.8
Salary Score
The national average salary for a Sarepta Therapeutics employee in the United States is $94,985 per year. Employees in the top 10 percent can make over $172,000 per year, while employees at the bottom 10 percent earn less than $52,000 per year.
Average Sarepta Therapeutics Salary
$94,985
yearly
$45.67 hourly
Updated March 16, 2023
Average Employee Earnings

Sarepta Therapeutics Diversity

9.3
Diversity Score
We calculated the diversity score of companies by measuring multiple factors, including the ethnic background, gender identity, and language skills of their workforce.

Sarepta Therapeutics Gender Distribution

Male
Male
44%
Female
Female
56%

Research Summary. Using a database of 30 million profiles, Zippia estimates demographics and statistics for Sarepta Therapeutics. Our estimates are verified against BLS, Census, and current job openings data for accuracy. After extensive research and analysis, Zippia's data science team found that:

  • Sarepta Therapeutics has 840 employees.

  • 56% of Sarepta Therapeutics employees are women, while 44% are men.

  • The most common ethnicity at Sarepta Therapeutics is White (66%).

  • 13% of Sarepta Therapeutics employees are Asian.

  • 12% of Sarepta Therapeutics employees are Hispanic or Latino.

  • The average employee at Sarepta Therapeutics makes $94,985 per year.

  • Sarepta Therapeutics employees are most likely to be members of the democratic party.

  • On average, employees at Sarepta Therapeutics stay with the company for 5.0 years.

Biggest Sarepta Therapeutics Locations

Jobs from companies you might like

Do you Work At Sarepta Therapeutics?

Help us make this company more transparent.

Sarepta Therapeutics Employee Political Affiliation

Sarepta Therapeutics employees are most likely to be members of the Democratic Party. The largest donation made to a political party by a Sarepta Therapeutics employee was by Ryszard Kole. Ryszard Kole donated $10,723 to the Democratic Party.

Sarepta Therapeutics

Parties

Democratic Party

75.0 %
-

Republican Party

25.0 %
-
Employee Political Donations
NameJob TitlePartyDonation
Ryszard KoleScientistDemocratic Party$10,723
Joan WoodHuman Resources CoordinatorDemocratic Party$10,000
Doug IngramPresident/Chief Executive OfficerRepublican Party$5,600
Douglas IngramChief Executive OfficerRepublican Party$3,700
Edward KayeChief Medical OfficerDemocratic Party$2,750
William CoverScientistRepublican Party$1,063
Diane BerryVice PresidentRepublican Party$1,000
Zheng XUReporting ManagerDemocratic Party$850
Michael WongPhysicianDemocratic Party$706
TIM KellyManager, Program ManagementDemocratic Party$550
Show More

Sarepta Therapeutics Financial Performance

10.0
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Sarepta Therapeutics Annual Revenue

$702M
$562M
$421M
$281M
$140M
$0
2016
2017
2018
2019
2020
2021

How Would You Rate The Company Culture Of Sarepta Therapeutics?

Have you worked at Sarepta Therapeutics? Help other job seekers by rating Sarepta Therapeutics.

Highest Paying Sarepta Therapeutics Competitors

Some of the competitors of Sarepta Therapeutics are Gilead Sciences, Vertex Pharmaceuticals, and Medivation. Employees at Gilead Sciences earn more than most of the competition, with an average yearly salary of $99,828. The employees at Vertex Pharmaceuticals earn an average yearly salary of $95,952 per year, and the salaries at Medivation average $94,135 per year.

Frequently Asked Questions about Sarepta Therapeutics

When was Sarepta Therapeutics founded?

Sarepta Therapeutics was founded in 1980.

How many Employees does Sarepta Therapeutics have?

Sarepta Therapeutics has 840 employees.

How much money does Sarepta Therapeutics make?

Sarepta Therapeutics generates $701.9M in revenue.

What industry is Sarepta Therapeutics in?

Sarepta Therapeutics is in the biotechnology industry.

What is Sarepta Therapeutics's mission?

Sarepta Therapeutics's mission statement is "To engineer precision genetic medicine for rare diseases that devastate lives and cut futures short."

What type of company is Sarepta Therapeutics?

Sarepta Therapeutics is a public company.

Who are Sarepta Therapeutics's competitors?

Sarepta Therapeutics competitors include Gilead Sciences, Regeneron, Merck, Seagen, Sanofi Genzyme, Zoetis, Vertex Pharmaceuticals, Medivation, Nitto Avecia, BioCryst Pharmaceuticals, Eurofins DiscoverX, XOMA, Biocoat.

Who works at Sarepta Therapeutics?

Douglas S. Ingram (CEO and President)

Marwan Fawaz (Founder)

Are You An Executive, HR Leader, Or Brand Manager At Sarepta Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Zippia gives an in-depth look into the details of Sarepta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sarepta Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sarepta Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sarepta Therapeutics. The data presented on this page does not represent the view of Sarepta Therapeutics and its employees or that of Zippia.

Sarepta Therapeutics may also be known as or be related to Sarepta Therapeutics, Sarepta Therapeutics Inc, Sarepta Therapeutics Inc. and Sarepta Therapeutics, Inc.